Henry A. Palmer C.E. FINALE 2026

 

Pharmacy’s Greatest Hits:

Classics, Covers, Remixes, and New Releases. Eight Hours, No Fillers

A LIVE (both virtual on Microsoft Teams and in-person) application-based continuing education activity for practicing pharmacists in all settings


Wednesday, December 16, 2026

7:30 am to 5:00 PM Eastern Standard Time

Leadership Center CT (New Location this year!)

613 New Britain Ave, Farmington, CT


Our virtual learners will enjoy streaming over Microsoft Teams

(new in 2026 as well!) if they can't make it in person!

Yvonne Riley-Poku, PharmD, RPh, Lecturer, Pharmacy Technician Certificate Program, CT State Community College, Bridgeport, CT

Wednesday, December 16 | 8:10-9:10 AM EST


LAW: The Buzz About the Expanding Scope of Practice for Pharmacy Technicians

0009-0000-26-056-L03-P (0.1 CEU or 1 contact hour) (Application-based)



At the conclusion of this presentation, pharmacists will be able to

  • DESCRIBE the current scope of practice of pharmacy technicians nationally
  • IDENTIFY advanced and specialty certifications and required credentials
  • DISCUSS new laws and proposed changes to scope of practice in CT and nationally, and their relevance in the workplace

Osama (Sam) Abdelghany, PharmD MHA, BCOP, Executive Director, Pharmacy Services, Yale-New Haven Hospital, New Haven, CT

Wednesday, December 16 | 9:15-10:15 AM EST


On Target, On Tour: A Pharmacist’s Guide to Oral Therapy in Lung Cancer

0009-0000-26-057-L01-P (0.1 CEU or 1 contact hour) (Application-based)



At the conclusion of this presentation, pharmacists will be able to

  • DESCRIBE the role of molecularly targeted oral therapies in the management of Lung Cancer
  • IDENTIFY clinically significant drug-drug and drug-food interactions associated with commonly used oral targeted therapies for lung cancer
  • RECOGNIZE treatment-related toxicities that require pharmacist intervention or referral to the oncology team
  • DEVELOP patient counseling, medication-reconciliation, and monitoring strategies to support the safe use of oral targeted therapies across community and health-system settings

Youssef Bessada PharmD, BCPS, Assistant Clinical Professor of Pharmacy Practice, UConn SoPPS, Storrs, CT

Wednesday, December 16 | 10:20-11:20 AM EST


Factor XI Inhibitors – Coming Soon to an Antithrombotic Management Program Near You

0009-0000-26-058-L01-P (0.1 CEU or 1 contact hour) (Application-based)



At the conclusion of this presentation, pharmacists will be able to

  • DESCRIBE the role of Factor XI/XIa in coagulation and explain the mechanistic rationale for targeting Factor XI/XIa to reduce thrombosis while preserving hemostasis
  • DIFFERENTIATE emerging Factor XI/XIa inhibitors based on molecule, mechanism of action, formulation, route of administration, pharmacokinetic characteristics, duration of effect, and monitoring considerations
  • EVALUATE emerging clinical evidence for Factor XI/XIa inhibitors across major potential indications, including atrial fibrillation, venous thromboembolism, secondary stroke prevention, cancer-associated thrombosis, and special populations in thrombotic conditions
  • IDENTIFY potential opportunities and challenges for Factor XI/XIa inhibitors within contemporary pharmacy practice and antithrombotic stewardship

Kelsey Giara, PharmD, Adjunct Faculty, UConn SoPPS, Medical Writer, Storrs, CT

Wednesday, December 16 | 11:25-12:25 PM EST


Changing the Migraine Prevention Playlist: A New Guideline Hits the Charts

0009-0000-26-059-L01-P (0.1 CEU or 1 contact hour) (Application-based)


At the conclusion of this presentation, pharmacists will be able to

  • DESCRIBE key updates in the 2026 AAN/AHS guideline for migraine prevention
  • COMPARE established and newer preventive therapies with respect to efficacy, safety, tolerability, and practical considerations
  • IDENTIFY patient-specific factors that influence selection of migraine preventive therapy
  • APPLY current guideline recommendations to pharmacist-led patient education, monitoring, and care coordination

Brett Feret, PharmD, Clinical Professor, Director Office of Experiential Education, University of Rhode Island, Kingston, RI

Wednesday, December 16 | 12:45-1:45 PM EST


IMMUNIZATION: The Updated Vaccine Playlist: Classics to New Releases

0009-0000-26-060-L06-P (0.1 CEU or 1 contact hour) (Application-based)



At the conclusion of this presentation, pharmacists will be able to

  • COMPARE and CONTRAST current CDC/ACIP immunization recommendations with guidance from other professional medical organizations to identify areas of alignment and differences in vaccine recommendations
  • DESCRIBE current recommendations for influenza, COVID-19, and RSV vaccinations, including notable clinical updates and areas of controversy
  • DISCUSS other updates to adult and pediatric immunization recommendations, including changes in vaccine schedules, safety considerations, and emerging vaccines relevant to pharmacy practice

Katelyn Galli, PharmD, BCCP, UConn School of Pharmacy and Pharmaceutical Sciences, Storrs, CT

Wednesday, December 16 | 1:50-2:50 PM EST


PATIENT SAFETY: Bad Medicine: Cardiovascular Drug Toxicities You Should Know by Heart

0009-0000-26-061-L05-P (0.1 CEU or 1 contact hour (Application-based)



At the conclusion of this presentation, pharmacists will be able to

  • IDENTIFY the most likely cardiovascular medication commonly implicated in toxicities and adverse effects based on a patient-specific presentation
  • ASSESS patient-specific and medication-related factors (e.g. organ dysfunction, electrolyte disturbances, drug interactions, comorbidities) that increase the risk of developing toxicity secondary to cardiac medications
  • RECOMMEND pharmacist interventions to manage or prevent toxicity secondary to cardiovascular medications

C. Michael White, PharmD, FCP, FCCP, FASHP, Distinguished Professor and Chair, Pharmacy Practice, UConn SoPPS, Storrs, CT

Wednesday, December 16 | 2:55-3:55 PM EST


PATIENT SAFETY: New risks: The Intoxicating Hemp Market: What Pharmacists Need to Know

0009-0000-26-062-L05-P (0.1 CEU or 1 contact hour) (Application-based)



At the conclusion of this presentation, pharmacists will be able to

  • DEFINE the definitional gap in the 2018 Farm Bill that lets intoxicating hemp cannabinoids bypass state cannabis regulation
  • IDENTIFY how CBD in hemp is turned into intoxicating hemp
  • LIST the major quality-control risks in hemp-derived products, including contamination, mislabeling, and inconsistent dosing
  • DESCRIBE the federal total-THC threshold and per-container cap that take effect mid-December 2026
  • APPLY knowledge to a case that will be discussed at the end of the presentation

Devra Dang, PharmD, CDCES, FNAP, Clinical Professor, UConn SoPPS, Storrs, CT

Wednesday, December 16 | 4:00-5:00 PM EST


The Ultimate Remixes of a Classic – Insulin Therapy in the Management of Type 2 Diabetes

0009-0000-26-063-L01-P (0.1 CEU or 1 contact hour) (Application-based)



At the conclusion of this presentation, pharmacists will be able to

  • LIST the major insulin formulations and their pharmacologic characteristics, including the newly once-weekly insulins
  • DIFFERENTIATE among insulin formulations and regimens based on clinical characteristics and practical considerations
  • EXPLAIN the current role of insulin therapy in the management of type 2 diabetes and how it has evolved in the setting of modern glucose-lowering therapies

We use a continuous class schedule format. This format does not include breaks but does include a 20-minute lunch period. Live activities on December 16th cost $60 for the first hour. Each additional activity costs $20. Early bird pricing ends December 8, 2026. Starting December 9, $25 is added to the total. We offer a 50% discount for UConn faculty/preceptors.


Refunds and Cancellations: The registration fee, less a $75 processing fee, is refundable for those who cancel their registration three (3) days prior to the program (by December 12) After that time, no refund is available.


Required Computer Hardware/Software: Virtual learners need an internet connection to see the slides, hear the speaker, participate in the chat, and have the opportunity to ask any questions via Microsoft Teams, and submit the evaluation afterward. We recommend using an updated Microsoft Edge or Google Chrome and your browser. The latest Firefox or Safari are also compatible with Teams. If you are using a desktop app you will need a dual-core processor and at least 4 GB of RAM, with 3 GB of available storage on Windows or 1.5 GB on Mac. 


Continuing Education Units

The University of Connecticut, School of Pharmacy and Pharmaceutical Sciences, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of Credit will be awarded at CE Finale based on full sessions attended and completed online evaluations. Pharmacists can earn up to 8 contact hours (0.80 CEU) one of which is a Law credit, one is an Immunization Credit, and two are Patient Safety credits.

Questions? We are here to help!


Contact: Heather Kleven

UConn School of Pharmacy Office of Continuing Education

Heather.Kleven@uconn.edu

tel. 860.486.2084


Facebook  LinkedIn